A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Parkinson’s Disease is a progressive neurological disorder that will eventually lead to a late or end‑stage with severe ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Autism spectrum disorder is tied to an increased risk for Parkinson disease, even after adjusting for depression and antipsychotic/antidepressant use.

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

Sara Penuela Rodriguez (left), an interdisciplinary neuroscience doctoral student, administers infrared laser light therapy ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people ...

The AI identified the presence of Parkinson's disease with an accuracy of over 95% through handwriting. There are various methods for diagnosing Parkinson's disease.

Discover vital resources and strategies for Parkinson's disease caregivers, from respite care to emotional support networks that help prevent burnout ...

A groundbreaking open-source computer program uses artificial intelligence to analyze videos of patients with Parkinson's disease and other movement disorders. The tool, called VisionMD, helps ...

Teleneurorehabilitation provides similar improvement in motor and nonmotor symptoms for patients with Parkinson’s disease as in-person rehab, new research suggests.